REACH: The Ready-to-Eat Meals for Cardiovascular Health Study

Sponsor
Washington State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05472454
Collaborator
(none)
30
1
13

Study Details

Study Description

Brief Summary

The proposed project explores the acceptability and health benefits of ready-to-eat (RTE) meals based on the Dietary Approaches to Stop Hypertension (DASH) eating plan. The researchers have developed 14 recipes following the DASH eating plan, which is recommended for the prevention of cardiovascular disease (CVD). The prepackaged meals will be processed using Washington State University (WSU) microwave technologies to ensure food safety. In this pilot study, a sample of 30 participants will be recruited by to study the impact of the DASH meals on blood pressure. All meals will be provided to participants, who will consume the meals daily over a period of 4 weeks. Daily and weekly monitoring of participants (blood pressure and weight) will allow us to gain a scientific understanding on the preventive power of healthy diets in lowering blood pressure and reducing CVD risk.

Condition or Disease Intervention/Treatment Phase
  • Other: Ready-to-eat meals
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Pre-post designPre-post design
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Ready-to-EAt Meals for Cardiovascular Health (REACH) Study
Anticipated Study Start Date :
Sep 1, 2022
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Ready-to-eat meals

Pre-Post

Other: Ready-to-eat meals
Participant group to consume ready-to-eat meals in accordance with the DASH diet for a period of 4 weeks.

Outcome Measures

Primary Outcome Measures

  1. Blood pressure [through study completion, measured weekly for 5 weeks]

    To determine dietary patterns on blood pressure using an omron blood pressure monitor.

Secondary Outcome Measures

  1. Body weight (kg) [through study completion, measured weekly for 5 weeks]

    To determine dietary patterns on body weight (kg) using a Angel USA 400 Pound Physician Digital Scale.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Male or female

  • 18 years old or older

  • BMI 18.5-40.0 kg/m2

  • Daily access to working internet, microwave, refrigerator, and freezer

  • English fluency

Exclusion Criteria:
  • Regular use of drugs that affect BP, including weight loss medications

  • Diagnosed hypertension OR systolic BP >130 and/or diastolic BP >80

  • Diagnosis of any hypotensive disorders OR systolic BP <100 and/or diastolic BP<65

  • Dietary restrictions, including allergy/intolerances

  • Presence or history of diabetes

  • Previous cardiac event, congestive heart failure, or angina

  • Weight loss or gain>15lb in previous 3 months

  • Following a diet to increase or decrease body weight

  • Cancer diagnosis or treatment in past 2 years

  • ≥14 alcoholic drinks/week for men; ≥ 7 alcoholic drinks/week for women

  • Use of nicotine, marijuana, or illicit drugs

  • Pregnancy, planned pregnancy, or breastfeeding

  • Inability to comprehend the nature of the study or instructions

  • No access to the internet

  • Planning to leave the Spokane area during the study

  • Not fluent in the English language

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Washington State University

Investigators

  • Principal Investigator: Pablo Monsivais, PhD, MPH, Washington State University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Washington State University
ClinicalTrials.gov Identifier:
NCT05472454
Other Study ID Numbers:
  • 19288-001
First Posted:
Jul 25, 2022
Last Update Posted:
Jul 25, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Washington State University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 25, 2022